Efficacy of a laparoscopic gastric restrictive device in an obese canine model

Xiaomei Guo, Samer Mattar, Scott E. Mimms, Jose A. Navia, Ghassan S. Kassab

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background: Bariatric surgery using laparoscopic techniques is the most effective treatment for morbid obesity. The objective of the study is to assess the safety and efficacy of a novel laparoscopic reversible gastric restrictive (RGR) device in a group of obese dogs. An implant was also performed in a cadaver to assess implant feasibility in a human. Methods: Four obese mongrel dogs were subjected to RGR implantation for 3 months followed by recovery for an additional 6 weeks after device removal. Food intake, body weight, radiographic barium imaging, and gastric endoscopy were used to monitor RGR performance before implant, after implant, and implant removal. An additional RGR laparoscopic implantation procedure was performed in a human cadaver. Results: The implanted obese dogs exhibited a significant decrease in food intake and body weight over 3 months with the RGR device. The reduction of food intake was sustained at an average of 46 % after implant and the excess weight loss reached an average of 75 % at the end of 12 weeks with recovery to approximately 78 % of baseline after 6 weeks of implant removal. Barium imaging and gastric endoscopy both confirmed passage for food through the restrictive device channel in the stomach. The RGR device was successfully implanted laparoscopically on the cadaver stomach in less than an hour. Conclusions: The RGR device is laparoscopically deliverable and removable with effective and sustainable weight loss over a 12-week period in an obese dog model. The implant is also technically feasible in man.

Original languageEnglish (US)
Pages (from-to)159-166
Number of pages8
JournalObesity Surgery
Volume24
Issue number1
DOIs
StatePublished - Jan 2014
Externally publishedYes

Fingerprint

Canidae
Stomach
Equipment and Supplies
Cadaver
Dogs
Eating
Barium
Endoscopy
Weight Loss
Body Weight
Device Removal
Bariatric Surgery
Morbid Obesity
Safety
Food

Keywords

  • Gastric restraint
  • Laparoscopic
  • Obese canine
  • Weight loss

ASJC Scopus subject areas

  • Surgery
  • Endocrinology, Diabetes and Metabolism
  • Nutrition and Dietetics

Cite this

Guo, X., Mattar, S., Mimms, S. E., Navia, J. A., & Kassab, G. S. (2014). Efficacy of a laparoscopic gastric restrictive device in an obese canine model. Obesity Surgery, 24(1), 159-166. https://doi.org/10.1007/s11695-013-1127-4

Efficacy of a laparoscopic gastric restrictive device in an obese canine model. / Guo, Xiaomei; Mattar, Samer; Mimms, Scott E.; Navia, Jose A.; Kassab, Ghassan S.

In: Obesity Surgery, Vol. 24, No. 1, 01.2014, p. 159-166.

Research output: Contribution to journalArticle

Guo, X, Mattar, S, Mimms, SE, Navia, JA & Kassab, GS 2014, 'Efficacy of a laparoscopic gastric restrictive device in an obese canine model', Obesity Surgery, vol. 24, no. 1, pp. 159-166. https://doi.org/10.1007/s11695-013-1127-4
Guo, Xiaomei ; Mattar, Samer ; Mimms, Scott E. ; Navia, Jose A. ; Kassab, Ghassan S. / Efficacy of a laparoscopic gastric restrictive device in an obese canine model. In: Obesity Surgery. 2014 ; Vol. 24, No. 1. pp. 159-166.
@article{9d32270b57c44ad59874d68be442e1ad,
title = "Efficacy of a laparoscopic gastric restrictive device in an obese canine model",
abstract = "Background: Bariatric surgery using laparoscopic techniques is the most effective treatment for morbid obesity. The objective of the study is to assess the safety and efficacy of a novel laparoscopic reversible gastric restrictive (RGR) device in a group of obese dogs. An implant was also performed in a cadaver to assess implant feasibility in a human. Methods: Four obese mongrel dogs were subjected to RGR implantation for 3 months followed by recovery for an additional 6 weeks after device removal. Food intake, body weight, radiographic barium imaging, and gastric endoscopy were used to monitor RGR performance before implant, after implant, and implant removal. An additional RGR laparoscopic implantation procedure was performed in a human cadaver. Results: The implanted obese dogs exhibited a significant decrease in food intake and body weight over 3 months with the RGR device. The reduction of food intake was sustained at an average of 46 {\%} after implant and the excess weight loss reached an average of 75 {\%} at the end of 12 weeks with recovery to approximately 78 {\%} of baseline after 6 weeks of implant removal. Barium imaging and gastric endoscopy both confirmed passage for food through the restrictive device channel in the stomach. The RGR device was successfully implanted laparoscopically on the cadaver stomach in less than an hour. Conclusions: The RGR device is laparoscopically deliverable and removable with effective and sustainable weight loss over a 12-week period in an obese dog model. The implant is also technically feasible in man.",
keywords = "Gastric restraint, Laparoscopic, Obese canine, Weight loss",
author = "Xiaomei Guo and Samer Mattar and Mimms, {Scott E.} and Navia, {Jose A.} and Kassab, {Ghassan S.}",
year = "2014",
month = "1",
doi = "10.1007/s11695-013-1127-4",
language = "English (US)",
volume = "24",
pages = "159--166",
journal = "Obesity Surgery",
issn = "0960-8923",
publisher = "Springer New York",
number = "1",

}

TY - JOUR

T1 - Efficacy of a laparoscopic gastric restrictive device in an obese canine model

AU - Guo, Xiaomei

AU - Mattar, Samer

AU - Mimms, Scott E.

AU - Navia, Jose A.

AU - Kassab, Ghassan S.

PY - 2014/1

Y1 - 2014/1

N2 - Background: Bariatric surgery using laparoscopic techniques is the most effective treatment for morbid obesity. The objective of the study is to assess the safety and efficacy of a novel laparoscopic reversible gastric restrictive (RGR) device in a group of obese dogs. An implant was also performed in a cadaver to assess implant feasibility in a human. Methods: Four obese mongrel dogs were subjected to RGR implantation for 3 months followed by recovery for an additional 6 weeks after device removal. Food intake, body weight, radiographic barium imaging, and gastric endoscopy were used to monitor RGR performance before implant, after implant, and implant removal. An additional RGR laparoscopic implantation procedure was performed in a human cadaver. Results: The implanted obese dogs exhibited a significant decrease in food intake and body weight over 3 months with the RGR device. The reduction of food intake was sustained at an average of 46 % after implant and the excess weight loss reached an average of 75 % at the end of 12 weeks with recovery to approximately 78 % of baseline after 6 weeks of implant removal. Barium imaging and gastric endoscopy both confirmed passage for food through the restrictive device channel in the stomach. The RGR device was successfully implanted laparoscopically on the cadaver stomach in less than an hour. Conclusions: The RGR device is laparoscopically deliverable and removable with effective and sustainable weight loss over a 12-week period in an obese dog model. The implant is also technically feasible in man.

AB - Background: Bariatric surgery using laparoscopic techniques is the most effective treatment for morbid obesity. The objective of the study is to assess the safety and efficacy of a novel laparoscopic reversible gastric restrictive (RGR) device in a group of obese dogs. An implant was also performed in a cadaver to assess implant feasibility in a human. Methods: Four obese mongrel dogs were subjected to RGR implantation for 3 months followed by recovery for an additional 6 weeks after device removal. Food intake, body weight, radiographic barium imaging, and gastric endoscopy were used to monitor RGR performance before implant, after implant, and implant removal. An additional RGR laparoscopic implantation procedure was performed in a human cadaver. Results: The implanted obese dogs exhibited a significant decrease in food intake and body weight over 3 months with the RGR device. The reduction of food intake was sustained at an average of 46 % after implant and the excess weight loss reached an average of 75 % at the end of 12 weeks with recovery to approximately 78 % of baseline after 6 weeks of implant removal. Barium imaging and gastric endoscopy both confirmed passage for food through the restrictive device channel in the stomach. The RGR device was successfully implanted laparoscopically on the cadaver stomach in less than an hour. Conclusions: The RGR device is laparoscopically deliverable and removable with effective and sustainable weight loss over a 12-week period in an obese dog model. The implant is also technically feasible in man.

KW - Gastric restraint

KW - Laparoscopic

KW - Obese canine

KW - Weight loss

UR - http://www.scopus.com/inward/record.url?scp=84893657314&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84893657314&partnerID=8YFLogxK

U2 - 10.1007/s11695-013-1127-4

DO - 10.1007/s11695-013-1127-4

M3 - Article

VL - 24

SP - 159

EP - 166

JO - Obesity Surgery

JF - Obesity Surgery

SN - 0960-8923

IS - 1

ER -